Clinical utility of laboratory testing in women with osteoporosis
暂无分享,去创建一个
[1] A. Need. Bone resorption markers in vitamin D insufficiency. , 2006, Clinica chimica acta; international journal of clinical chemistry.
[2] S. Cummings,et al. Design of the Fracture Intervention Trial , 2005, Osteoporosis International.
[3] J. Rubin. Regulation of skeletal remodeling by biomechanical input , 2003, Osteoporosis International.
[4] S. Adami,et al. Prevalence of hypovitaminosis D in elderly women in Italy: clinical consequences and risk factors , 2003, Osteoporosis International.
[5] G. Leb,et al. Assessment of vitamin D and calcium status in healthy adult Austrians , 2003, European journal of clinical investigation.
[6] M. Jergas,et al. Assessment of prevalent and incident vertebral fractures in osteoporosis research , 2003, Osteoporosis International.
[7] M. Calvo,et al. Prevalence of vitamin D insufficiency in Canada and the United States: importance to health status and efficacy of current food fortification and dietary supplement use. , 2003, Nutrition reviews.
[8] B. L. Riggs,et al. Role of the vitamin D‐endocrine system in the pathophysiology of postmenopausal osteoporosis , 2003, Journal of cellular biochemistry.
[9] E. Schrumpf,et al. Secondary Osteoporosis in Liver Transplant Recipients: a Longitudinal Study in Patients With and Without Cholestatic Liver Disease , 2003, Scandinavian journal of gastroenterology.
[10] H. Vapaatalo,et al. Suppression of Pro-Inflammatory Cytokine Release by Selective Inhibition of Inducible Nitric Oxide Synthase in Mucosal Explants from Patients with Ulcerative Colitis , 2003, Scandinavian journal of gastroenterology.
[11] E. Schrumpf,et al. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease. , 2003, Scandinavian journal of gastroenterology.
[12] M. Horowitz,et al. Relationship between serum 25-hydroxyvitamin D and bone resorption markers in vitamin D insufficiency. , 2002, Bone.
[13] D. Meier,et al. Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women. , 2002, The Journal of clinical endocrinology and metabolism.
[14] B. Çakır,et al. Secondary osteoporosis in women , 2002, Archives of Gynecology and Obstetrics.
[15] G. Fick,et al. Vitamin D insufficiency in a population of healthy western Canadians. , 2002, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[16] L. Fitzpatrick. Secondary causes of osteoporosis. , 2002, Mayo Clinic proceedings.
[17] L. Wehren. The role of the primary care physician in diagnosis and management of osteoporosis. , 2002, International journal of fertility and women's medicine.
[18] B. Çakır,et al. Secondary osteoporosis in women. A retrospective analysis. , 2002, Archives of gynecology and obstetrics.
[19] J. Glowacki,et al. Fractures in the elderly and vitamin D. , 2002, The journal of nutrition, health & aging.
[20] Jacques P. Brown,et al. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. , 2002, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[21] C. Cooper,et al. Secondary prevention of osteoporosis: when should a non-vertebral fracture be a trigger for action? , 2001, QJM : monthly journal of the Association of Physicians.
[22] Monica Duarte,et al. Calcium‐parathyroid hormone‐vitamin D axis and metabolic bone disease in chronic viral liver disease , 2001, Journal of gastroenterology and hepatology.
[23] P. Lips,et al. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. , 2001, Endocrine reviews.
[24] D. Bauer,et al. Risk for Fracture in Women with Low Serum Levels of Thyroid-Stimulating Hormone , 2001, Annals of Internal Medicine.
[25] R. Harwood,et al. Hypovitaminosis D and 'functional hypoparathyroidism'-the NoNoF (Nottingham Neck of Femur) study. , 2001, Age and ageing.
[26] Hein Df. Osteoporosis. An overview of the National Osteoporosis Foundation clinical practice guide. , 2000 .
[27] C. Cooper,et al. Comparison of the European and USA Practice Guidelines for Osteoporosis , 2000, Trends in Endocrinology & Metabolism.
[28] D. Heinemann. Osteoporosis. An overview of the National Osteoporosis Foundation clinical practice guide. , 2000, Geriatrics.
[29] H. Hagino,et al. The change of bone mineral density in secondary osteoporosis and vertebral fracture incidence , 1999, Journal of Bone and Mineral Metabolism.
[30] T. Weber,et al. SECONDARY OSTEOPOROSIS : Diagnostic Considerations , 1998 .
[31] R. Nuti,et al. Bone Mass and Bone Loss in Secondary Osteoporosis , 1998 .
[32] S. Cummings,et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures , 1996, The Lancet.
[33] S. Majumdar,et al. Noninvasive assessment of bone mineral and structure: State of the art , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[34] C. Rosen,et al. Vitamin D and Bone Status in Elderly Women , 1996, Orthopedic nursing.
[35] Denise Janse van Rensburg. Guidelines for the early detection of osteoporosis and prediction of fracture risk. Council of the National Osteoporosis Foundation. , 1996, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[36] S. Cummings,et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. , 1995, The New England journal of medicine.
[37] G. Samsa,et al. Likelihood ratios with confidence: sample size estimation for diagnostic test studies. , 1991, Journal of clinical epidemiology.
[38] M. F. Parry,et al. A Retrospective Analysis , 1990 .
[39] G. D. Whedon,et al. Vitamin D and bone health in the elderly. , 1982, The American journal of clinical nutrition.